These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 3940737

  • 1. Effect of streptokinase on fibrinogen and related proteins in plasma.
    Bowie LJ, Kinney R, Vye M, Eckert B, Kwaan HC.
    Clin Chem; 1986 Jan; 32(1 Pt 1):67-70. PubMed ID: 3940737
    [Abstract] [Full Text] [Related]

  • 2. Biological effects of the administration of an equimolar streptokinase-plasminogen complex in man.
    Verstraete M, Vermylen J, Holleman W, Barlow GH.
    Thromb Res; 1977 Aug; 11(2):227-36. PubMed ID: 905974
    [No Abstract] [Full Text] [Related]

  • 3. The thrombolytic activity of streptokinase in the rabbit.
    English PD, Smith RA, Dupe RJ, Green J, Hibbs MJ.
    Thromb Haemost; 1981 Aug 28; 46(2):535-7. PubMed ID: 7302893
    [Abstract] [Full Text] [Related]

  • 4. ON THE COMBINED ADMINISTRATION OF STREPTOKINASE AND PANCREATIC TRYPSIN INHIBITOR.
    VERSTRAETE M, VERMYLEN J, VERMYLEN C, DEVREKER RA.
    Thromb Diath Haemorrh; 1964 Dec 31; 12():391-5. PubMed ID: 14254698
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of thrombosis by sequential therapy with ancrod followed by streptokinase. Clinical pharmacology and rheology.
    Forbes CD, Barbenell J, Prentice CR.
    Haemostasis; 1976 Dec 31; 5(6):348-54. PubMed ID: 1017726
    [Abstract] [Full Text] [Related]

  • 6. Fibrinogen degradation products in plasma following induced hyperfibrinolysis.
    Chek JB, Panchenko NI.
    East Afr Med J; 2000 Apr 31; 77(4):217-20. PubMed ID: 12858907
    [Abstract] [Full Text] [Related]

  • 7. [Effect of fibrin-fibrinogenolysis on the determination of the fibrinogen content and fibrin-fibrinogen degradation products (FDP) by means of the fibrin polymerization time (FPT test)].
    Vorlová Z, Dyr IE.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979 Apr 31; 106(5-6):967-70. PubMed ID: 94893
    [No Abstract] [Full Text] [Related]

  • 8. The formation of a fibrinogen-activator complex by the action of streptokinase.
    Chesterman CN, Cederholm-Williams SA, Allington MJ, Sharp AA.
    Thromb Res; 1977 Mar 31; 10(3):421-30. PubMed ID: 854878
    [No Abstract] [Full Text] [Related]

  • 9. Vampire bat salivary plasminogen activator promotes robust lysis of plasma clots in a plasma milieu without causing fluid phase plasminogen activation.
    Hare TR, Gardell SJ.
    Thromb Haemost; 1992 Aug 03; 68(2):165-9. PubMed ID: 1412162
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The fibrinolytic response to ancrod therapy: characterization of fibrinogen and fibrin degradation products.
    Prentice CR, Hampton KK, Grant PJ, Nelson SR, Nieuwenhuizen W, Gaffney PJ.
    Br J Haematol; 1993 Feb 03; 83(2):276-81. PubMed ID: 8457476
    [Abstract] [Full Text] [Related]

  • 17. Systemic fibrinolytic activity and inhibitor levels during treatment of deep vein thrombosis with urokinase and streptokinase.
    Theiss W, Asbeck F, Kriessmann A, Trübestein G, Knoch K, de Swart CA, Marbert GA, van de Loo JC.
    Thromb Haemost; 1983 Oct 31; 50(3):664-8. PubMed ID: 6196852
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.